Skip to main content

Table 1 Patient clinical characteristics

From: Cholesterol efflux alterations in adolescent obesity: role of adipose-derived extracellular vesical microRNAs

  n Median (IQR) p value*
Anthropometric
 Sex (F, M) 93 71, 22
 Age (year) 93 17 (3) 0.04
 Height (cm) 93 164 (13) 0.3
 Weight (kg) 93 126 (45) 0.36
 BMI (kg/m2) 93 45.2 (13.2) 0.38
HDL function
 Cholesterol efflux capacity 69 0.85 (0.17)
Lipid panel
 Total cholesterol 69 127 (34) 0.89
 LDL-C, mg/dL 69 77 (38) 0.86
 HDL-C, mg/dL 69 40 (13) 0.11
 Triglycerides 69 56 (36) 0.48
NMR spectroscopy
 LDL particle concentration, nmol/L 69 933 (453) 0.15
 HDL particle concentration, µmol/L 69 25.6 (5.3) 0.46
 VLDL particle concentration, nmol/L 69 28.4 (20.4) 0.09
 LDL particle size, nm 69 20.5 (9) < 0.01
 HDL particle size, nm 69 9.2 (0.7) 0.01
 VLDL particle size, nm 69 48.4 (8.35) 0.17
Metabolic assessment
 Lipoprotein insulin resistance score 69 46 (25) 0.45
Inflammation assessment
 GlycA 69 429 (90) 0.15
  1. Data are presented as Median (IQR). p value for Pearson product moment correlation coefficient for cholesterol efflux capacity